Novel Gain-of-Function Mutation in STAT-1 Protein with ALPS-like presentation

Publication: LymphoSign Journal
9 January 2025

Abstract

Background: Germline mutations in STAT1 lead to primary immunodeficiency affecting both intrinsic and innate immunity. These immunodeficiencies can manifest as either loss-of-function (LOF) mutations or gain-of-function (GOF) mutations. LOF mutations result in a significant reduction in STAT1 protein functionality and are associated with Mendelian susceptibility to mycobacterial disease. Conversely, GOF mutations occur when a gene undergoes a change that enhances its normal function, resulting in an overactive form of the protein. Heterozygous STAT1 GOF mutations are the predominant cause of Chronic Mucocutaneous Candidiasis (CMC) in individuals with inborn errors of immunity. Aim: The study aims to report the clinical features, immune profile, and unique characteristics of a 9-year-old female patient with GOF mutations in STAT-1. Results: We present a case of an 8-year-old female who has been genetically diagnosed with a GOF mutation in the STAT 1 gene. The patient's clinical presentation includes lymphadenopathy, splenomegaly, the presence of non-caseating granulomas, and cytopenia. Notably, there is no evidence of mycobacterial infection typically associated with LOF mutation, nor any indication of fungal, viral, or malignant conditions. Furthermore, there are no signs of endocrine abnormalities such as thyroiditis or diabetes mellitus. The patient's immunological profile reveals evidence of autoimmunity, including symptoms of arthralgia and oral ulcers. Manual calculations of DN T cells showed no increase in their numbers. The patient did not exhibit typical signs of chronic mucocutaneous candidiasis (CMC) but presented with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features, expanding the clinical spectrum of STAT1 GOF mutations. Discussion: The clinical and immunological characteristics of GOF mutations in STAT-1 vary considerably among case reports. The current case had no evidence of CMC, thus raising the possibility of ALPS-like syndrome as an extension of the commonly addressed features of GOF mutations. Statement of novelty: The absence of CMC in a patient with GOF mutations in STAT-1 is a rare presentation that should be considered when evaluating patients with inborn errors of immunity.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Just-IN

History

Received: 30 September 2024
Accepted manuscript online: 9 January 2025

Authors

Affiliations

Bashair Mohammed Ibrahim, M.D [email protected]
King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia., Allergy and immunology
King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia., Allergy and immunology
Mohammad Alsalamah
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF

View PDF

Media

Tables

Media

Share Options

Share

Share the article link

Share on social media